Gold Coast cancer survival rates improve according to latest data

The latest Gold Coast cancer data has been revealed this morning, showing improved survival rates for Gold Coasters.

Cancer Council Queensland’s Viertel Cancer Research Centre has released 2015 data and trends for, survival, mortality and prevalence.

Around 3825 Gold Coast locals are diagnosed with cancer each year, and about 1160 people die from the disease.


The data also shows the top five most commonly diagnosed cancers in the Gold Coast region are prostate cancer, melanoma, breast cancer, colorectal cancer and lung cancer.

Cancer Council Queensland CEO Ms Chris McMillan says overall, the number of cancers diagnosed each year in Queensland has more than tripled in the last three decades, from 8298 in 1982 to about 27,788 cases in 2015.

“Approximately 585 local men are diagnosed with prostate cancer each year and sadly about 90 local men die from the disease,” Ms McMillan said.

“Melanoma is the second most common cancer for this region, with around 560 people diagnosed each year”.

“About 480 local women are diagnosed with breast cancer each year and around 440 locals are diagnosed with colorectal cancer each year”.

“Lung cancer remains the region’s biggest cancer killer, with around 335 locals diagnosed each year and about 240 locals dying from the disease.”

It’s not all bad news though, the research has also found that across all cancer types, the average five-year relative survival rate for 2011-2015 is 71 per cent, up from 69 per cent for the period of 2006-2010.

“While survival rates are improving, if current trends continue into the future, cancer will remain the leading burden of disease, impacting an increasing number of individuals and families, and placing an even greater burden on the community and the health system.

“We all have a role to play in cancer control through reducing our own personal risk of some types of cancer by making healthy lifestyle choices, enabling early detection by getting to know our bodies and participating in recommended screening programs, and supporting continued investment into cancer research and support services,” Ms McMillan said.

More information is available here.